| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 08/10/2005 | EP1561741A1 Method for deuteration or tritiation of heterocyclic ring |
| 08/10/2005 | CN1652791A Synergistic enhancement of cognitive ability |
| 08/10/2005 | CN1651424A Production method of high purity tea polyphenol and caffeine |
| 08/09/2005 | US6926763 Gramnegative, grampositive bacteria infections |
| 08/09/2005 | CA2188164C Benzamide compounds and pharmaceutical use thereof |
| 08/04/2005 | WO2005026167A8 Process for preparing famciclovir |
| 08/04/2005 | US20050171172 platelet derived growth factor receptor; anticarcinogenic; leukemia; specific kinase inhibitors; accurate targeting with limited inhibition of other pathways; reduced toxicity |
| 08/04/2005 | US20050171171 colony-stimulating factor receptor (c- FMS)-like tyrosine kinase 3; anticarcinogenic; leukemia;specific kinase inhibitors; accurate targeting with limited inhibition of other pathways; reduced toxicity |
| 08/04/2005 | US20050171125 Novel alkoxypyridine-derivatives |
| 08/04/2005 | US20050171124 Famciclovir monohydrate |
| 08/04/2005 | US20050171092 Chemical compounds |
| 08/04/2005 | US20050171049 Compounds for the treatment of ischemia |
| 08/04/2005 | US20050169982 Topiramate sodium, topiramate lithium, topiramate potassium, or polymorphs, solvates, hydrates, dehydrates, co-crystals, anhydrous, and amorphous forms; seizures, obesity, neuropathic pain, affective disorders, tobacco cessation, chronic fatigue syndrome, drug addiction; highly soluble, bioavailability |
| 08/03/2005 | EP1558615A1 Purine compounds and use thereof as cannabinoid receptor ligands |
| 08/03/2005 | EP1399446B1 2,6,9-substituted purine derivatives and their use in the treatment of proliferative disorders |
| 08/03/2005 | CN1213047C Puring derivatives inhibitors of tyrosine kinase SYK |
| 07/28/2005 | WO2005048948A3 Urea derivatives as kinase modulators |
| 07/28/2005 | US20050165232 Phenyl substituted imidaopyridines and phenyl substituted benzimidazoles |
| 07/28/2005 | US20050165074 inhibitors of protein tyrosine kinases, for preventing of cancer, cardiovascular disease, inflammation or multiple sclerosis |
| 07/28/2005 | US20050165031 1-(4-(3-(Pyridin-4-yl)propoxy)phenyl)-3-(5-tert-butylisoxazol-3-yl)urea; inhibits protein tyrosine kinases or a specific kinase or kinase class; for for treating and preventing conditions and diseases such as cancer, hematologic malignancies, cardiovascular disease, inflammation or multiple sclerosis |
| 07/28/2005 | US20050165024 Urea derivatives as kinase modulators |
| 07/28/2005 | US20050165007 Benzimidazoles and analogs thereof as antivirals |
| 07/28/2005 | US20050164235 Modified iRNA agents |
| 07/27/2005 | EP1556383A1 Process for preparing famciclovir |
| 07/27/2005 | EP1556140A2 Novel compounds |
| 07/27/2005 | EP1556129A2 Compositions and methods for inducing osteogenesis |
| 07/27/2005 | EP0986561B1 Compounds for inhibition of ceramide-mediated signal transduction |
| 07/27/2005 | CN1646538A Topiramate salts and compositions comprising and methods of making and using the same |
| 07/27/2005 | CN1646532A Production method of 2, 6-dihalopurine |
| 07/27/2005 | CN1646531A Thioxanthine derivatives as myeloperoxidase inhibitors |
| 07/27/2005 | CN1646141A Modified nucleosides for treatment of viral infections and abnormal cellular proliferation |
| 07/27/2005 | CN1646132A Methods of treating patients suffering from movement disorders |
| 07/26/2005 | CA2190202C Cyclopentenecarboxamide derivative, method for preparing the same and bicycloamide derivative used therein |
| 07/21/2005 | US20050159570 Molecularly imprinted polymer obtainable by polymerization of hexamethyl phosphonamide based monomer in presence of a template molecule and extraction; crosslinking; separation of enantiomers, resolution |
| 07/21/2005 | DE10360835A1 New bicyclic imidazole derivatives are dipeptidylpeptidase-IV inhibitors useful to treat e.g. arthritis, obesity, allograft transplantation and calcitonin-induced osteoporosis |
| 07/21/2005 | DE10359026A1 Verfahren zur Herstellung von Tetrahydrogeranylaceton A process for preparing tetrahydrogeranylacetone |
| 07/20/2005 | EP1554278A2 Xanthine derivatives, production thereof and use thereof as medicines |
| 07/20/2005 | CN1642955A Novel alkoxypyridine-derivatives |
| 07/20/2005 | CN1642923A Peptide nucleic acid oligomers from 1-benzenesulfonyl-3-amino acid side chain-4-(2-nucleobase(acetyl))-piperazin-2-ones |
| 07/19/2005 | US6919455 4-((9-((3-Cyclopentyloxy-4-methoxy)benzyl)-6,8 dimethylpurin)-2-yl-3-oxypropyl)pyridine N-oxide chemical intermediate; phosphodiesterase inhibitors; antiasthmatic and antiinflammatory agents; chronic obstructive pulmonary disease |
| 07/19/2005 | US6919337 Treatment of sexual dysfunction, particularly male erectile dysfunction. |
| 07/14/2005 | WO2005063766A2 Bicyclic heterocyclic p-38 kinase inhibitors |
| 07/14/2005 | WO2005063751A1 4’-substituted carbovir-and abacavir-derivatives as well as related compounds with hiv and hcv antiviral activity |
| 07/14/2005 | WO2005063750A1 Bicyclic imidazole compounds, the production thereof and their use as medicaments |
| 07/14/2005 | WO2004046148A8 Novel xanthin derivatives, production and use thereof as medicaments |
| 07/14/2005 | US20050154005 Administering to a subject in need of such treatment an effective amount of 1,1'-[1,4-(phenylenebis(methylene))]bis-1,4,8,11-tetraazacyclotetradecane or a pharmaceutical composition thereof, wherein the inhibition of CXCR4 receptor binding effects treatment or amelioration of said condition |
| 07/14/2005 | CA2548326A1 Bicyclic heterocyclic p-38 kinase inhibitors |
| 07/13/2005 | EP1551839A1 Process for preparing 9-[4-acetoxy-3-(acetoxymethyl)but-1-yl]-2-aminopurine |
| 07/13/2005 | EP1551838A1 Method for reducing residual alcohols in crystalline valacyclovir hydrochloride |
| 07/13/2005 | EP1551837A1 Phosphodiesterase 4 inhibitors |
| 07/13/2005 | EP1551410A2 Novel compounds |
| 07/13/2005 | CN1636597A Compounds for the treatment of female sexual dysfunction |
| 07/12/2005 | US6916850 Pyruvate derivatives |
| 07/12/2005 | US6916819 Benzimidazole and pyridylimidazole derivatives |
| 07/12/2005 | US6916606 Electrochemiluminescent assays |
| 07/07/2005 | US20050148606 2,6-Dioxo-1,2,3,6-tetrahydropurine derivatives; dipeptidyl peptidase IV inhibitors for diabetes and obesity |
| 07/07/2005 | US20050148605 Modulation of protein tyrosine kinases for treatment of diseases with prodrugs |
| 07/06/2005 | EP1550662A1 Novel adenine compound and use thereof |
| 07/06/2005 | EP1301187B1 Purine-2,6-diones which are inhibitors of the enzyme dipeptidyl peptidase iv (dpp-iv) |
| 07/06/2005 | CN1634913A Process for preparing effective constituent in tea |
| 07/05/2005 | US6914054 Treatment with a 1' 2' and/or 3' nucleoside or a pharmaceutically acceptable salt or prodrug; nontoxic |
| 06/30/2005 | WO2005058898A2 Purine compounds which can be used as phosphodiesterase (pde) type iv inhibitors |
| 06/30/2005 | WO2005058228A2 Comt inhibitors |
| 06/30/2005 | WO2005021548A3 Substituted 8-heteroaryl xanthines |
| 06/30/2005 | US20050143436 N-acylamino with fused nitrogen heterocyclic ring compound; capase enzyme inhibitors; antiinflammatory agents; oral bioavailability; autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases |
| 06/30/2005 | US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 06/30/2005 | US20050143400 Process for preparing famciclovir |
| 06/30/2005 | US20050143377 Bicyclic imidazole derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 06/30/2005 | CA2548300A1 Comt inhibitors |
| 06/29/2005 | EP1546391A2 Energy transfer dyes, terminators and use thereof |
| 06/29/2005 | EP1546371A1 Substrates for o6-alkylguanine-dna alkyltransferase |
| 06/29/2005 | EP1546125A2 Fluorescent labeling reagents with multiple donors and acceptors |
| 06/29/2005 | EP1546108A1 1,4-substituted cyclohexane derivatives |
| 06/29/2005 | EP1274701B1 [1,4']-bipiperidine compounds |
| 06/29/2005 | EP1021186B1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IkappaB-alpha |
| 06/28/2005 | US6911424 2′-fluoronucleosides |
| 06/23/2005 | WO2005056508A1 Method for the production of tetrahydrogeranylacetone |
| 06/23/2005 | WO2005056016A1 Preventive and/or therapeutic agent for higher brain dysfunction |
| 06/23/2005 | US20050137213 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis; antiproliferative, anticarcinogenic, antimetabolic agents; tubulin and topoisomerase II inhibitors; fungicides; synergistic administration with other anticarcinogenic agents |
| 06/23/2005 | US20050137162 New COMT inhibitors for the treatment of depression and impaired cognition |
| 06/23/2005 | US20050137161 Methods and compositions for treating hepatitis C virus |
| 06/23/2005 | US20050136437 Nanoparticles for delivery of nucleic acids and stable double-stranded RNA |
| 06/23/2005 | DE10355304A1 Neue 8-(Piperazin-1-yl)-und 8-([1,4]Diazepan-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel New 8- (piperazin-1-yl) -and 8 - ([1,4] diazepan-1-yl) -xanthines, their preparation and their use as medicaments |
| 06/23/2005 | CA2550130A1 Agents for preventing and/or treating higher brain dysfunctions |
| 06/23/2005 | CA2548262A1 Method for the production of tetrahydrogeranylacetone |
| 06/22/2005 | EP1469856A4 8-heteroaryl xanthine adenosine a sb 2b /sb receptor antagonists |
| 06/21/2005 | US6909437 Data driven layout engine |
| 06/21/2005 | US6908935 Calcium receptor modulating agents |
| 06/16/2005 | WO2005028479A3 Hiv replication inhibiting purine derivatives |
| 06/16/2005 | WO2005007658A3 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 06/16/2005 | US20050131229 Production method of 2,6-dihalopurine |
| 06/16/2005 | US20050130993 Synthesis and purification of valacyclovir |
| 06/16/2005 | US20050130985 8-(piperazin-1yl)- and 8-([1,4]diazepan-1yl)-xanthines, the preparation thereof and their use as pharmaceutical composition |
| 06/15/2005 | EP1539188A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 06/15/2005 | EP0882727B9 Novel purine derivatives |
| 06/15/2005 | CN1206226C Method for preparing effective anti-virus cyclopropane derivative and intermediate used thereof |
| 06/14/2005 | US6906190 Inhibitors for de novo-RNA polymerases and methods of identifying targets for same |
| 06/14/2005 | US6906076 Inactivating a nuclear localization signal of a protein by contacting the protein with a compound that binds reversibly; parasiticides; viricides |
| 06/09/2005 | WO2005051952A1 Method for producing adenine derivative |
| 06/09/2005 | WO2005051951A1 A2b adenosine receptor antagonists |